Abiomed

ABMD
Delayed Nasdaq - 04/25 10:00:00 pm
268.13USD
-1%
Prev.270.8300
Open268.9000
High278.4707
Low265.0000
Volume600 162
Financials
Sales 2019 781 M
EBIT 2019 228 M
R. net 2019 235 M
Tréso. 2019 482 M
Rend. 2019 -
P/E ratio 2019 52,77
P/E ratio 2020 54,74
EV / Sales 2019 14,9x
EV / Sales 2020 11,5x
Capitalization 12 089 M
Company
Abiomed specializes in the development, manufacture and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows:
- product sales (96.1%): heart pumps (Impella brand);
- service provision (3.8%): including preventive...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2019-05-02 Earnings Release
Trading Rating :
Investor Rating :
Latest news
04/24ABIOMED INC : Other Events (form 8-K)
AQ
04/23ABIOMED : Clinical Data Highlights Advantages of Protected PCI to Enable Complete Revascularization and Improved Patient Quality of Life
BU
04/11ABIOMED : Fourth Quarter Fiscal 2019 Earnings and Conference Call Notification
BU
04/05ABIOMED : Cardiogenic Shock Survival Rates Improve Significantly in Three Years since Impella FDA PMA Approval
AQ
04/04ABIOMED : Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval
BU
03/22ABIOMED INC : Change in Directors or Principal Officers (form 8-K)
AQ
03/19ABIOMED : Impella RP Post-Approval Study Data Presented at ACC 2019
AQ
03/18ABIOMED : Impella RP Post-Approval Study Data Presented at ACC 2019
BU
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance285314341
Spread/Res.-5,9%-15%-21%
Spread/Supp.6,6%6,6%4,5%
Support251251257